Institutional investors purchased a net $1.3 million shares of ECTE during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 6.90% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
| Other institutional | 6.57% |
| Individual stakeholders | 16.97% |
| Mutual fund holders | 0.34% |